Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

North American Healthcare distribution

3 Mar 2015 07:00

RNS Number : 3167G
Toumaz Limited
03 March 2015
 

3 March 2015

 

Toumaz Limited

 

North American Healthcare distribution

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for healthcare and consumer audio, has agreed with NantHealth LLC to terminate its North American distribution agreement for its SensiumVitals® wireless vital signs monitoring system. This change, instigated by the Group, will allow Toumaz to address the key US market in a substantially more focused manner.

 

The North American distribution rights for SensiumVitals® revert to Toumaz with immediate effect, in return for an undisclosed payment which will have a minimal impact on the Group's overall cash position. The region accounts for c.50% of the potential $1.5 billion global market for hospital-based wireless monitoring [1].

 

The Group will position a small business development team in the US to support existing customers, follow through on leads generated by NantHealth LLC, introduce SensiumVitals® to the larger hospital groups and evaluate Toumaz's options for an accelerated deployment in the US. The Group will provide a further update on its strategy later this year.

 

In Rest of World territories, interest in the system continues to build. SensiumVitals® has been deployed in hospitals in the UK, France, Italy, Germany, Portugal, and Australia - as well as the US.

 

A growing number of these deployments are moving from initial evaluation to full-scale integration with hospital IT systems. Worldwide, the Group has a qualified pipeline of 200 hospitals.

 

[1] Source OnWorld, Novasecta, company estimates

 

Anthony Sethill, CEO of Toumaz said:

 

"This is an important forward step for the Group. Our experience in both the US and Rest of World territories highlights the need for a fully focused business development team to manage the introduction of SensiumVitals®.

 

"Interest in the SensiumVitals® system is strong and, with our own dedicated business development team, we will be able to accelerate the rate of deployments in North America."

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

 

Jonathan Apps, Chief Financial Officer

 

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Daniel Harris

 

 

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Chantal Woolcock

 

 

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital audio devices.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUPCWUPAGMP
Date   Source Headline
14th Oct 20197:30 amRNSSuspension - Frontier Smart Technologies Group
11th Oct 201910:42 amRNSResult of EGM and Suspension of Trading on AIM
8th Oct 20195:30 pmRNSFrontier Smart Technologies Group
3rd Oct 201910:00 amRNSClosure of Romania Operations
11th Sep 20199:30 amRNSBoard Appointments
9th Sep 20196:21 pmRNSRecommended Statutory Merger & AIM Cancellation
6th Sep 20193:20 pmRNSBlock Listing Update
5th Sep 201912:47 pmRNSHolding(s) in Company
3rd Sep 20194:39 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20198:54 amRNSAmendment to Standby Facility
2nd Sep 20195:23 pmRNSHolding(s) in Company
30th Aug 20192:21 pmRNSDirector/PDMR Dealing
30th Aug 20197:00 amRNSHalf-Year Results
29th Aug 20197:00 amRNSResponse to Science Group Statement
28th Aug 20194:23 pmRNSHolding(s) in Company
28th Aug 20198:47 amRNSFrontier Investment Update and Buy-Back
23rd Aug 201912:31 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
23rd Aug 201912:30 pmRNSConfirmation of Refinancing
21st Aug 20197:00 amRNSBoard Transition, Refinancing and Strategy
13th Aug 20197:00 amRNSBoard Change
7th Aug 201911:20 amRNSResponse to announcement by Frontier
7th Aug 20197:00 amRNSTrading & Discussion Update and EGM Requisition
31st Jul 20193:30 pmRNSExercise of Options and Total Voting Rights
30th Jul 20197:00 amRNSBoard Changes
22nd Jul 201910:09 amRNSHolding(s) in Company
22nd Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
19th Jul 20196:09 pmRNSExercise of Options and Total Voting Rights
19th Jul 20197:00 amRNSHolding(s) in Company
19th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
18th Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
17th Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
16th Jul 20197:00 amRNSHolding(s) in Company
16th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
15th Jul 20198:02 amRNSHolding(s) in Company
15th Jul 20197:00 amRNSFurther Response to Science Group Offer
15th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
12th Jul 20194:07 pmRNSInvestment in Frontier Smart Technologies Group
12th Jul 20193:00 pmRNSFurther Response to Science Group Offer
12th Jul 20197:00 amRNSHolding(s) in Company
12th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
8th Jul 20197:00 amRNSHolding(s) in Company
8th Jul 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
5th Jul 20197:00 amRNSFurther Response to Offer & update on discussions
2nd Jul 201912:20 pmRNSPublication of Offer Document
1st Jul 20199:01 amRNSResponse to Science Group Statement
1st Jul 20197:00 amRNSCash offer for Frontier Smart Technologies Grp Ltd
27th Jun 20194:10 pmRNSExercise of Options and Total Voting Rights
14th Jun 201911:40 amRNSInvestment in Frontier Smart Technologies Grp Ltd
14th Jun 20198:31 amRNSResponse to Science Group's announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.